N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci - PubMed

Comparative Study

N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci

F W Goldstein et al. Antimicrob Agents Chemother. 1994 Sep.

Abstract

The in vitro activities of the N,N-dimethylglycyl-amino derivative of minocycline (DMG-MINO) and 6-dimethyl-6-dexoxytetracycline (DMG-DMDOT), members of a new generation of tetracyclines, were evaluated by an agar dilution method and were compared with those of tetracycline and minocycline against 224 tetracycline-resistant and 73 tetracycline-susceptible recent clinical isolates of gram-positive cocci, including multiple-antibiotic-resistant methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. The MICs of DMG-MINO and DMG-DMDOT were up to 500- to 2,000-fold lower than those of tetracycline against methicillin-resistant S. aureus and Streptococcus pneumoniae (MIC for 50% of strains tested [MIC50], < 0.06 microgram/ml). Against Streptococcus groups A, B, C, and G and Enterococcus faecalis, the MIC50 was 0.5 microgram/ml. MIC50s were greater only for coagulase-negative staphylococci (2 micrograms/ml). These data indicate that DMG-MINO and DMG-DMDOT are very potent drugs, and further in vitro and in vivo studies are warranted.

Similar articles

• In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.

  Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP. Testa RT, et al. Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7. doi: 10.1128/AAC.37.11.2270. Antimicrob Agents Chemother. 1993. PMID: 8285606 Free PMC article.

• Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.

  Kenny GE, Cartwright FD. Kenny GE, et al. Antimicrob Agents Chemother. 1994 Nov;38(11):2628-32. doi: 10.1128/AAC.38.11.2628. Antimicrob Agents Chemother. 1994. PMID: 7872759 Free PMC article.

• Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.

  Johnson DM, Jones RN. Johnson DM, et al. Diagn Microbiol Infect Dis. 1996 Jan;24(1):53-7. doi: 10.1016/0732-8893(95)00250-2. Diagn Microbiol Infect Dis. 1996. PMID: 8988765

• Recent developments in tetracycline antibiotics.

  Sum PE, Sum FW, Projan SJ. Sum PE, et al. Curr Pharm Des. 1998 Apr;4(2):119-32. Curr Pharm Des. 1998. PMID: 10197036 Review.

• The glycylcyclines: a comparative review with the tetracyclines.

  Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ. Zhanel GG, et al. Drugs. 2004;64(1):63-88. doi: 10.2165/00003495-200464010-00005. Drugs. 2004. PMID: 14723559 Review.

Cited by

• In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

  Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT. Petersen PJ, et al. Antimicrob Agents Chemother. 1999 Apr;43(4):738-44. doi: 10.1128/AAC.43.4.738. Antimicrob Agents Chemother. 1999. PMID: 10103174 Free PMC article.

• Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.

  Hoellman DB, Pankuch GA, Jacobs MR, Appelbaum PC. Hoellman DB, et al. Antimicrob Agents Chemother. 2000 Apr;44(4):1085-8. doi: 10.1128/AAC.44.4.1085-1088.2000. Antimicrob Agents Chemother. 2000. PMID: 10722519 Free PMC article.

• Antifungal Azoles as Tetracycline Resistance Modifiers in Staphylococcus aureus.

  Mahey N, Tambat R, Verma DK, Chandal N, Thakur KG, Nandanwar H. Mahey N, et al. Appl Environ Microbiol. 2021 Jul 13;87(15):e0015521. doi: 10.1128/AEM.00155-21. Epub 2021 Jul 13. Appl Environ Microbiol. 2021. PMID: 33990311 Free PMC article.

• In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.

  Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Alvarez J, Picazo JJ; Spanish Group of Tigecycline. Betriu C, et al. Antimicrob Agents Chemother. 2002 Mar;46(3):892-5. doi: 10.1128/AAC.46.3.892-895.2002. Antimicrob Agents Chemother. 2002. PMID: 11850282 Free PMC article.

• In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria.

  van Ogtrop ML, Andes D, Stamstad TJ, Conklin B, Weiss WJ, Craig WA, Vesga O. van Ogtrop ML, et al. Antimicrob Agents Chemother. 2000 Apr;44(4):943-9. doi: 10.1128/AAC.44.4.943-949.2000. Antimicrob Agents Chemother. 2000. PMID: 10722495 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database